PharmaTutor
9 May 2011

Applications are Invited for the Post of Executive, Officer - Dispensing, Officer / Sr. Officer - QC @ Ahmedabad Based USFDA & MHRA Approved Pharmaceutical Formulation Company

Established in 2002. Total Professional Approach. Professionals handling assignments for Specific Sectors/Industy with rich experience & background. Working with Reputed Clients having Top Ranking in threir Sectors

Post: Executive, Officer-Dispensing, Officer/Sr. Officer-QC

9 May 2011
Job as a Medical Representative @ TYD Ideas Consultants

TYD IDeas is a HR Consultancy with varied projects in Training, HR services. They are currently looking out for Medical Represenatatives for one of their Clients. Kindly send in your resumes since the postions are across India.

Post: Medical Representative

[adsense:336x280:8701650588]

9 May 2011
Work as a Business Officer in Royal Pharmaceuticals

It’s immense pleasure & proud for us to introduce ourselve as newly established but a prominent company in the field of pharmaceuticals in India.
They are dealing with sales and promotion of pharmaceutical products.
They are located at Ahmednagar, Maharashtra of India.
They are established with the aim of providing quality medicines and other pharmaceutical products with affordable rates to the society.

9 May 2011
A Review on Conduct and Analysis of Bioavailability and Bioequivalence Studies

About Author: 1. Shah Dhaval D., M.Pharm-II Semester, Quality Assurance Department, Gyan Vihar School of Pharmacy, Jaipur, India
2. Sharma Anil, M.Pharm, H.O.D. Quality Assurance Department, Gyan Vihar School of Pharmacy, Jaipur, India

Reference ID: PHARMATUTOR-ART-1050

Abstract
Generic pharmaceutical products need to confirm to the same standard of quality, efficacy and safety as required of the originator’s (innovator) product. Spefically, the generic product should be therapeutically equivalent and interchangable with the reference product. Testing the bioequivalence between a test product pharmacetically equivalent or a pharmaceutical alternative and a suitable reference product in a pharmacokinetic study with a limited no of subjects is one way of demonstrating therapeutic equivalence. Generic drug applications are termed “abbreviated” because they are generally not required to include preclinical and clinical data to establish safety and effectiveness. This article provides the information about important aspect involved in bioequivalence and regulatory requirment for bioequivalence study.

9 May 2011
GPAT Paper, 2011 | Get GPAT question Paper

Q.76    Which of the following statements are true for ginseng root?
[P] It is among the most traded plant material of Brazil. [Q] It is obtained from Panax ginseng and Panax quinquefolium. [R] It is obtained from young plants of six months to one year age. [S] It contains derivatives of protopanaxadiol.
(A)   P&Q    (B)   R&S    (C)   Q&R    (D)   Q & S

8 May 2011
GPAT Paper, 2011 | Find out GPAT question Paper

GPAT-2011 PAPER

{Answers are on the end page of question Paper}

8 May 2011
Opening for Senior Analyst / Senior Analyst, Business Analytics - Pharma Reporting @ Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

8 May 2011
Job as a Training Manager in SAVA Medica - 2 Openings

SAVA Medica Limited is a leading pharmaceutical company based in India.
Human life is precious to us. That is why we, at SAVA Medica, are committed to provide such products which can improve human health & life at affordable cost.
To accomplish our aim we, at SAVA Medica, are engaged in manufacturing & marketing of the branded generic medicines at affordable prices.

7 May 2011
Co-processed excipients: an overview of formulation aspects, physical characteristics and role as a pharmaceutical-aid

About Authors: Biswajit Panda1*, Abhinav Raoot1, Vaishali Kilor1, Nidhi Sapkal2
Dept of Pharmaceutics1 and Dept of Pharmaceutical Chemistry2
Gurunanak College of Pharmacy, Nagpur

Reference ID: PHARMATUTOR-ART-1049

Abstract
Excipients are all substances contained in a dosage form other than the active substance. Tablets are the most commonly used dosage form because of the ease of manufacturing, convenience in administration, accurate dosing and stability compared to oral liquids and direct compression is the preferred method for the preparation of tablets because of several advantages. In order to justify the high rise in new drug development and high industrial output demand, new excipients with purpose satisfying characteristics are the need of the hour.New combinations of existing excipients are an interesting option for improving excipient functionality now-a-days. The current review article is prepared to have a look over the recent development in excipient technology and the approaches involved in development of such excipients. It signifies the synergistic outcome of the combination of excipients taking their material property into consideration. It also emphasises on the particular material properties in terms of physic-mechanical that are useful to overcome the limitation of existing excipients. All the developed co-processed excipients are enlisted highlighting their multi-functional and beneficial characteristics. Regulatory issues concerned with the development of new excipient are also discussed.

7 May 2011
Assets of Pharmacovigilance, Its Necessity and Future in INDIA in coming five years.

About Authors: Mrugank BP1,  Mangala L2,  Hareesha RP3
Department(s) and institution(s)
1. National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmacy Practice, M.Pharm (Student)
2. Gauhati Medical College and Hospital (GMCH), Department of Pharmacology, Prof and Head; Chief academic co-ordinator, NIPER-Ghy.
3. National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmacy Practice, M.Pharm (Student)

Reference ID: PHARMATUTOR-ART-1048

Abstract:
Background: "Pharmacovigilance is the science and activity relating the detection, assessment, understanding and prevention of adverse effects or any other possible drug - related problems." [1]

Literature:Periodic safety update reports (PSUR)[2]and Medical Dictionary for Regulatory Activities (MedDRA)[3]are two important assets for maintenance of Drug safety Pharmacovigilancesystem as they are designed to represent the safety data on a particular drug from all the sources and geographical regions in the worldand to understand internationally, accepted clinically validated medical terminology for medical coding respectively.